The Future of Medicine: How 3D Printing Is Transforming Pharmaceuticals

Abstract

Three-dimensional printing technology is transforming pharmaceutical manufacturing by shifting from conventional mass production to additive manufacturing, with a strong emphasis on personalized medicine. The integration of bioinks and AI-driven optimization is further enhancing this innovation, enabling drug production with precise dosages, tailored drug-release profiles, and unique multi-drug combinations that respond to individual patient needs.

This advancement is significantly impacting healthcare by accelerating drug development, encouraging innovative pharmaceutical designs, and enhancing treatment efficacy. Traditional pharmaceutical manufacturing follows a one-size-fits-all approach, which often fails to meet the specific requirements of patients with unique medical conditions. In contrast, 3D printing, coupled with bioink formulations, allows for on-demand drug production, reducing dependency on large-scale manufacturing and storage.

AI-powered design and process optimization further refine dosage forms, printability, and drug release mechanisms, ensuring precision and efficiency in drug manufacturing. These advancements have the potential to lower overall healthcare costs while improving patient adherence to medication regimens. This review explores the potential, challenges, and environmental benefits of 3D pharmaceutical printing, positioning it as a key driver of next-generation personalized medicine.

Introduction

The emerging 3D printing technology signifies a groundbreaking evolution in the production of medicines, transitioning from conventional technological methods to additive manufacturing. This advancement is particularly revolutionizing the pharmaceutical industry [1]. For example, in hospital settings, 3D printing will facilitate the creation of personalized drug dosages, helping patients with specific medical needs. Similarly, in community pharmacies, this technology will enable on-demand drug production, ensuring medications are tailored to individual patients, thereby reducing wait times and enhancing treatment outcomes [2].

Three-dimensional pharmaceutical printing is a pioneering advancement in personalized medicine, utilizing layer-by-layer deposition of pharmaceutical materials to produce customized medications with distinct structures, precise dosages, and tailored drug combinations [3]. This cutting-edge approach not only speeds up drug development but also drives innovation in pharmaceutical design, making it possible to create complex drug formulations that were previously hardly possible to produce [4]. Three-dimensional printing technology addresses one of the most pressing issues of healthcare: the move towards personalized treatment. Traditional mass production of medications often falls short, as the “one-size-fits-all” approach does not account for the unique requirements of each patient [5]. The rise of personalized medicine, powered by advancements in the understanding of genetics and lifestyles, highlights the need for more customized treatments [3,6,7]. Integrating 3D printing into healthcare settings revolutionizes clinical pharmacy by making drug manufacturing more accessible and adaptable to patient needs [8]. This not only enhances medication compliance and addresses logistical limitations but also has the potential to be cost-effective in the long run [9]. For instance, the on-demand production of drugs could reduce the need for large-scale manufacturing and storage, potentially lowering overall healthcare costs [10].

However, the widespread integration of 3D printing in the pharmaceutical industry faces numerous challenges that must be addressed for its successful adoption. Key obstacles include regulatory compliance, quality assurance, and engagement from healthcare professionals, all of which require urgent attention [11]. Establishing standardized guidelines for the production, safety, and efficacy of 3D-printed medications is essential to ensure consistency and reliability in patient care. The approval by FDA of the first 3D-printed drug marked a significant breakthrough, demonstrating the potential of additive manufacturing in pharmaceuticals. However, this milestone also highlights the ongoing need for clear regulatory frameworks that can keep pace with rapid technological advancements [12,13]. These frameworks must ensure patient safety, dosage precision, and product stability, while also facilitating innovation in drug design and production. Additionally, collaboration between regulatory agencies, pharmaceutical companies, and medical professionals will be critical in establishing best practices and gaining widespread acceptance of 3D-printed pharmaceuticals in clinical and commercial settings.

Our review will focus on innovative dosage forms enabled by 3D printing, underscoring the role of this technology in the future of pharmaceutical innovation. An overview of the current specifications, requirements, and production processes for customized 3D-printed pharmaceutical dosage forms will be provided, identifying the challenges and opportunities within the industry. It will also consider the potential environmental impact of 3D printing, such as reducing waste from unused or expired medications. Finally, this review will outline future directions and perspectives, based on the long-term impact of 3D printing on the pharmaceutical industry, healthcare delivery, and patient outcomes.

This review will discuss the transformative potential of 3D printing in pharmaceuticals, offering insights into its current applications and future possibilities for advancing personalized medicine. Although there are many recent excellent reviews on the 3D printing of pharmaceuticals [2,4,9,13,14], our review explores in detail the advantages and disadvantages of 3D-printed pharmaceuticals, highlighting innovations that enable new tablet shapes, multilayered drug substances, and novel excipients. Our review emphasizes the role of 3D printing in developing personalized treatments for vulnerable groups like pediatric and geriatric patients or patients with chronic diseases and its unique ability to simplify complex drug regimens. Additionally, it examines innovative dosage forms made possible by 3D printing, discusses the future of the 3D technology for the printing of pharmaceuticals and provides an overview of the specifications, requirements, and production processes for customized 3D-printed drugs.

Download the full article as PDF here: The Future of Medicine- How 3D Printing Is Transforming Pharmaceuticals

or read it here

Table 2. Innovative excipients used for the development of chewable tablets

Bernatoniene, J.; Stabrauskiene, J.; Kazlauskaite, J.A.; Bernatonyte, U.; Kopustinskiene, D.M. The Future of Medicine: How 3D Printing Is Transforming Pharmaceuticals. Pharmaceutics 2025, 17, 390. https://doi.org/10.3390/pharmaceutics17030390

Read also our introduction article on 3D Printing here: